However, high acute s-IGFBP-1 was significantly related to poor functional outcome 7 years poststroke, even when patients who died were excluded, which may implicate that s-IGFBP-1 was of a lower significance in the acute to early subacute phase of stroke. The gene discussed is IGFBP1; the disease is stroke disorder.